Tablon, Elena D.
HRN: 28-68-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2026
CEFTAZIDIME 1GM (VIAL)
03/29/2026
04/05/2026
IV
500
Q24hrs
VAP
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: